Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system

Michael B.A. Oldstone, Paul Blount, Peter J. Southern, Peter W. Lampert

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

The mechanism(s) by which infectious or malignant material is cleared by the host has long been an area of intensive study. We have used the murine model of infection with lymphocytic choriomeningitis virus (LCMV) to look at immune clearance during persistent infection. LCMV was selected because the mouse is its natural host, it easily induces acute or persistent infection in vivo, and the mechanism by which it is cleared in vivo during acute infection is now well understood1-8. Clearance, although associated with several antiviral immune effector mechanisms1, is primarily dependent on the activity of virus-specific cytotoxic T lymphocytes (CTL) restricted by H-2 molecules of the mouse major histocompatibility complex (MHC)4-8. If these cells fail to generate or are depleted, progression from acute to persistent infection occurs1,9,10. Here, using molecular probes, we show that viral nucleic acid sequences, viral proteins and infectious materials can be efficiently and effectively cleared by adoptive transfer of antiviral H-2-restricted lymphocytes bearing the Lyt 2+ phenotype. Viral materials are cleared from a wide variety of tissues and organs where they normally lodge during persistent infection. Unexpectedly, the mode by which viral materials are removed from the central nervous system (CNS) differed markedly from the mechanism of clearance occurring at other sites. These observations indicate the possible use of adoptive lymphocyte therapy for treatment of persistent infections and suggest that immune clearance of products from the CNS probably occurs by a process distinct from those in other organs.

Original languageEnglish (US)
Pages (from-to)239-243
Number of pages5
JournalNature
Volume321
Issue number6067
DOIs
StatePublished - Dec 1 1986

Fingerprint

Virus Diseases
Central Nervous System
Infection
Lymphocytic choriomeningitis virus
Antiviral Agents
Lymphocytes
Molecular Probes
Adoptive Transfer
Cytotoxic T-Lymphocytes
Viral Proteins
Major Histocompatibility Complex
Nucleic Acids
Viruses
Phenotype
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. / Oldstone, Michael B.A.; Blount, Paul; Southern, Peter J.; Lampert, Peter W.

In: Nature, Vol. 321, No. 6067, 01.12.1986, p. 239-243.

Research output: Contribution to journalArticle

Oldstone, Michael B.A. ; Blount, Paul ; Southern, Peter J. ; Lampert, Peter W. / Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. In: Nature. 1986 ; Vol. 321, No. 6067. pp. 239-243.
@article{16f6e8ddaed6494fbc321e0a2e347eb0,
title = "Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system",
abstract = "The mechanism(s) by which infectious or malignant material is cleared by the host has long been an area of intensive study. We have used the murine model of infection with lymphocytic choriomeningitis virus (LCMV) to look at immune clearance during persistent infection. LCMV was selected because the mouse is its natural host, it easily induces acute or persistent infection in vivo, and the mechanism by which it is cleared in vivo during acute infection is now well understood1-8. Clearance, although associated with several antiviral immune effector mechanisms1, is primarily dependent on the activity of virus-specific cytotoxic T lymphocytes (CTL) restricted by H-2 molecules of the mouse major histocompatibility complex (MHC)4-8. If these cells fail to generate or are depleted, progression from acute to persistent infection occurs1,9,10. Here, using molecular probes, we show that viral nucleic acid sequences, viral proteins and infectious materials can be efficiently and effectively cleared by adoptive transfer of antiviral H-2-restricted lymphocytes bearing the Lyt 2+ phenotype. Viral materials are cleared from a wide variety of tissues and organs where they normally lodge during persistent infection. Unexpectedly, the mode by which viral materials are removed from the central nervous system (CNS) differed markedly from the mechanism of clearance occurring at other sites. These observations indicate the possible use of adoptive lymphocyte therapy for treatment of persistent infections and suggest that immune clearance of products from the CNS probably occurs by a process distinct from those in other organs.",
author = "Oldstone, {Michael B.A.} and Paul Blount and Southern, {Peter J.} and Lampert, {Peter W.}",
year = "1986",
month = "12",
day = "1",
doi = "10.1038/321239a0",
language = "English (US)",
volume = "321",
pages = "239--243",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "6067",

}

TY - JOUR

T1 - Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system

AU - Oldstone, Michael B.A.

AU - Blount, Paul

AU - Southern, Peter J.

AU - Lampert, Peter W.

PY - 1986/12/1

Y1 - 1986/12/1

N2 - The mechanism(s) by which infectious or malignant material is cleared by the host has long been an area of intensive study. We have used the murine model of infection with lymphocytic choriomeningitis virus (LCMV) to look at immune clearance during persistent infection. LCMV was selected because the mouse is its natural host, it easily induces acute or persistent infection in vivo, and the mechanism by which it is cleared in vivo during acute infection is now well understood1-8. Clearance, although associated with several antiviral immune effector mechanisms1, is primarily dependent on the activity of virus-specific cytotoxic T lymphocytes (CTL) restricted by H-2 molecules of the mouse major histocompatibility complex (MHC)4-8. If these cells fail to generate or are depleted, progression from acute to persistent infection occurs1,9,10. Here, using molecular probes, we show that viral nucleic acid sequences, viral proteins and infectious materials can be efficiently and effectively cleared by adoptive transfer of antiviral H-2-restricted lymphocytes bearing the Lyt 2+ phenotype. Viral materials are cleared from a wide variety of tissues and organs where they normally lodge during persistent infection. Unexpectedly, the mode by which viral materials are removed from the central nervous system (CNS) differed markedly from the mechanism of clearance occurring at other sites. These observations indicate the possible use of adoptive lymphocyte therapy for treatment of persistent infections and suggest that immune clearance of products from the CNS probably occurs by a process distinct from those in other organs.

AB - The mechanism(s) by which infectious or malignant material is cleared by the host has long been an area of intensive study. We have used the murine model of infection with lymphocytic choriomeningitis virus (LCMV) to look at immune clearance during persistent infection. LCMV was selected because the mouse is its natural host, it easily induces acute or persistent infection in vivo, and the mechanism by which it is cleared in vivo during acute infection is now well understood1-8. Clearance, although associated with several antiviral immune effector mechanisms1, is primarily dependent on the activity of virus-specific cytotoxic T lymphocytes (CTL) restricted by H-2 molecules of the mouse major histocompatibility complex (MHC)4-8. If these cells fail to generate or are depleted, progression from acute to persistent infection occurs1,9,10. Here, using molecular probes, we show that viral nucleic acid sequences, viral proteins and infectious materials can be efficiently and effectively cleared by adoptive transfer of antiviral H-2-restricted lymphocytes bearing the Lyt 2+ phenotype. Viral materials are cleared from a wide variety of tissues and organs where they normally lodge during persistent infection. Unexpectedly, the mode by which viral materials are removed from the central nervous system (CNS) differed markedly from the mechanism of clearance occurring at other sites. These observations indicate the possible use of adoptive lymphocyte therapy for treatment of persistent infections and suggest that immune clearance of products from the CNS probably occurs by a process distinct from those in other organs.

UR - http://www.scopus.com/inward/record.url?scp=0022508921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022508921&partnerID=8YFLogxK

U2 - 10.1038/321239a0

DO - 10.1038/321239a0

M3 - Article

C2 - 3086743

AN - SCOPUS:0022508921

VL - 321

SP - 239

EP - 243

JO - Nature

JF - Nature

SN - 0028-0836

IS - 6067

ER -